BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7525491)

  • 1. Critical residues of the Mycobacterium leprae LSR recombinant protein discriminate clinical activity in erythema nodosum leprosum reactions.
    Singh S; Jenner PJ; Narayan NP; Ramu G; Colston MJ; Prasad HK; Nath I
    Infect Immun; 1994 Dec; 62(12):5702-5. PubMed ID: 7525491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein.
    Singh S; Narayanan NP; Jenner PJ; Ramu G; Colston MJ; Prasad HK; Nath I
    Infect Immun; 1994 Jan; 62(1):86-90. PubMed ID: 7505263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.
    Saini C; Prasad HK; Rani R; Murtaza A; Misra N; Shanker Narayan NP; Nath I
    Clin Vaccine Immunol; 2013 May; 20(5):673-82. PubMed ID: 23446220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL).
    Rada EM; Zambrano EA; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):222-5. PubMed ID: 16830648
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Mycobacterium leprae antigens from a cosmid library: characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients.
    Sela S; Thole JE; Ottenhoff TH; Clark-Curtiss JE
    Infect Immun; 1991 Nov; 59(11):4117-24. PubMed ID: 1840579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an antigenic domain on Mycobacterium leprae protein antigen 85B, which is specifically recognized by antibodies from patients with leprosy.
    Filley E; Thole JE; Rook GA; Nagai S; Waters M; Drijfhout JW; Rinke de Wit TF; De Vries RR; Abou-Zeid C
    J Infect Dis; 1994 Jan; 169(1):162-9. PubMed ID: 7506279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
    Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum.
    Dias AA; Silva CO; Santos JP; Batista-Silva LR; Acosta CC; Fontes AN; Pinheiro RO; Lara FA; Machado AM; Nery JA; Sarno EN; Pereira GM; Pessolani MC
    J Immunol; 2016 Sep; 197(5):1905-13. PubMed ID: 27474073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
    Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10.
    Pacheco FS; Prata RBDS; Brandão SS; Ferreira H; Rodrigues TF; Brandão Dos Santos J; da Silva CO; Tavares IF; Mendes MA; Rodrigues ACDP; Machado AM; Nery JADC; Amadeu TP; Moraes MO; Sarno EN; Schmitz V
    Immunohorizons; 2020 Feb; 4(2):47-56. PubMed ID: 32034084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Mycobacterium leprae recombinant 18-kDa proteins in leprosy.
    Hussain R; Dockrell HM; Kifayet A; Daud A; Watson JD; Chiang TJ; Stoker NG
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):368-75. PubMed ID: 1282140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes and antibody levels in blisters over human leprosy skin lesions with or without erythema nodosum leprosum.
    Scollard DM; Bhoopat L; Kestens L; Vanham G; Douglas JT; Moad J
    Clin Immunol Immunopathol; 1992 Jun; 63(3):230-6. PubMed ID: 1623643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
    Schwerer B; Meeker HC; Sersen G; Levis WR
    Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 28-kDa protein from Mycobacterium leprae is a target of the human antibody response in lepromatous leprosy.
    Cherayil BJ; Young RA
    J Immunol; 1988 Dec; 141(12):4370-5. PubMed ID: 3058804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.